Vaccines against Tuberculosis: Where Are We and Where Do We Need to Go?

被引:357
作者
Ottenhoff, Tom H. M. [1 ]
Kaufmann, Stefan H. E. [2 ]
机构
[1] Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands
[2] Max Planck Inst Infect Biol, Deptartment Immunol, Berlin, Germany
基金
比尔及梅琳达.盖茨基金会;
关键词
T-CELL RESPONSES; HEPARIN-BINDING HEMAGGLUTININ; CALMETTE-GUERIN VACCINATION; DRUG-RESISTANT TUBERCULOSIS; HOST-PATHOGEN INTERACTIONS; MYCOBACTERIUM-BOVIS BCG; IMMUNE-RESPONSE; LATENT INFECTION; EXTRAPULMONARY DISSEMINATION; POLYFUNCTIONAL CD4(+);
D O I
10.1371/journal.ppat.1002607
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
In this review we discuss recent progress in the development, testing, and clinical evaluation of new vaccines against tuberculosis (TB). Over the last 20 years, tremendous progress has been made in TB vaccine research and development: from a pipeline virtually empty of new TB candidate vaccines in the early 1990s, to an era in which a dozen novel TB vaccine candidates have been and are being evaluated in human clinical trials. In addition, innovative approaches are being pursued to further improve existing vaccines, as well as discover new ones. Thus, there is good reason for optimism in the field of TB vaccines that it will be possible to develop better vaccines than BCG, which is still the only vaccine available against TB.
引用
收藏
页数:12
相关论文
共 145 条
[41]   Higher human CD4 T cell response to novel Mycobacterium tuberculosis latency associated antigens Rv2660 and Rv2659 in latent infection compared with tuberculosis disease [J].
Govender, Lerisa ;
Abel, Brian ;
Hughes, E. Jane ;
Scriba, Thomas J. ;
Kagina, Benjamin M. N. ;
de Kock, Marwou ;
Walzl, Gerhard ;
Black, Gillian ;
Rosenkrands, Ida ;
Hussey, Gregory D. ;
Mahomed, Hassan ;
Andersen, Peter ;
Hanekom, Willem A. .
VACCINE, 2010, 29 (01) :51-57
[42]   Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guerin mutants that secrete listeriolysin [J].
Grode, L ;
Seiler, P ;
Baumann, S ;
Hess, J ;
Brinkmann, V ;
Eddine, AN ;
Mann, P ;
Goosmann, C ;
Bandermann, S ;
Smith, D ;
Bancroft, GJ ;
Reyrat, JM ;
van Soolingen, D ;
Raupach, B ;
Kaufmann, SHE .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (09) :2472-2479
[43]   Auxotrophic vaccines for tuberculosis [J].
Guleria, I ;
Teitelbaum, R ;
McAdam, RA ;
Kalpana, G ;
Jacobs, WR ;
Bloom, BR .
NATURE MEDICINE, 1996, 2 (03) :334-337
[44]   Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages [J].
Gutierrez, MG ;
Master, SS ;
Singh, SB ;
Taylor, GA ;
Colombo, MI ;
Deretic, V .
CELL, 2004, 119 (06) :753-766
[45]   The potential impact of helminth infection on trials of novel tuberculosis vaccines [J].
Hatherill, Mark ;
Adams, Vera ;
Hughes, Jane ;
De Kock, Marwou ;
Mavakla, Wendy ;
Pienaar, Bernadette ;
Mahomed, Hassan ;
Hussey, Gregory ;
Hanekom, Willem A. .
VACCINE, 2009, 27 (35) :4743-4744
[46]   HLA-E-dependent presentation of Mtb-derived antigen to human CD8+ T cells [J].
Heinzel, AS ;
Grotzke, JE ;
Lines, RA ;
Lewinsohn, DA ;
McNabb, AL ;
Streblow, DN ;
Brand, VM ;
Grieser, HJ ;
Belisle, JT ;
Lewinsohn, DM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (11) :1473-1481
[47]   Persistence of DNA from Mycobacterium tuberculosis in superficially normal lung tissue during latent infection [J].
Hernández-Pando, R ;
Jeyanathan, M ;
Mengistu, G ;
Aguilar, D ;
Orozco, H ;
Harboe, M ;
Rook, GAW ;
Bjune, G .
LANCET, 2000, 356 (9248) :2133-2138
[48]   The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children [J].
Hesseling, Anneke C. ;
Marais, Ben J. ;
Gie, Robert P. ;
Schaaf, H. Simon ;
Fine, Paul E. M. ;
Godfrey-Faussett, Peter ;
Beyers, Nulda .
VACCINE, 2007, 25 (01) :14-18
[49]   A New Recombinant Bacille Calmette-Guerin Vaccine Safely Induces Significantly Enhanced Tuberculosis-Specific Immunity in Human Volunteers [J].
Hoft, Daniel F. ;
Blazevic, Azra ;
Abate, Getahun ;
Hanekom, Willem A. ;
Kaplan, Gilla ;
Soler, Jorge H. ;
Weichold, Frank ;
Geiter, Larry ;
Sadoff, Jerald C. ;
Horwitz, Marcus A. .
JOURNAL OF INFECTIOUS DISEASES, 2008, 198 (10) :1491-1501
[50]   Baseline Ad5 serostatus does not predict Ad5 HIV vaccine-induced expansion of adenovirus-specific CD4+ T cells [J].
Hutnick, Natalie A. ;
Carnathan, Diane G. ;
Dubey, Sheri A. ;
Cox, Kara S. ;
Kierstead, Lisa ;
Ratcliffe, Sarah J. ;
Robertson, Michael N. ;
Casimiro, Danilo R. ;
Ertl, Hildegund C. J. ;
Betts, Michael R. .
NATURE MEDICINE, 2009, 15 (08) :876-878